DSGN – design therapeutics, inc. (US:NASDAQ)

Sec Filings

Form SC 13D/A Design Therapeutics, Filed by: Logos Global Management LP
Form 4 Design Therapeutics, For: Aug 09 Filed by: William Arsani
Form 144 Design Therapeutics, Filed by: Logos SPV 1 LP
Form 10-Q Design Therapeutics, For: Jun 30
Form 8-K Design Therapeutics, For: Aug 05
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com